Business
Sernova Announces Change of Location of Annual Meeting of Shareholders
(via TheNewswire) LONDON, ONTARIO - TheNewswire - May 26, 2020 - Serno...
About this update from Sernova Biotherapeutics Inc
[{"type":"text","content":"Sernova Announces Change of Location of Annual Meeting of Shareholders(via TheNewswire)\n \n \nLONDON, ONTARIO - TheNewswire - May 26, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) (the \"Corporation\" or \"Sernova\") announces that the Board of Directors of the Corporation have considered current COVID-19 public health restrictions and determined it to be in the best interests of the Corporation and its shareholders to change the location of the Corporation's annual meeting of shareholders (\"AGM\") to the offices of Sernova at 700 Collip Circle, Suite 114, London, Ontario N6G 4X8. The AGM will be held on Friday, May 29, 2020, at 12:00 p.m. (Eastern Time). Shareholders are reminded to submit their votes by proxy before the proxy deadline of 12:00 p.m. (Eastern Time) on Wednesday, May 27, 2020. Shareholders may choose to attend the meeting by teleconference but will not be able to vote via teleconference. All other matters of the AGM remain the same as published in the AGM proxy materials mailed to the shareholders and posted at www.sedar.com.\n\n\n \nThe conference call details for shareholders to call into the AGM are set out below. \n\n\n \nUS Toll-Free: + 1-877-366-0711 \n\n\n \nCanada Toll-Free: + 1-866-627-1651 \n\n\n \nInt'l Toll-Free: + 1-302-709-8446 \n\n\n \nThe conference participant passcode is 109 985 50. \n\n\n \nFollowing the AGM, Sernova will hold a CEO conference call at 1:00 p.m. (Eastern Time) for its shareholders and investors. The CEO conference call details are set out below.\n\n\n \nhttps://zoom.us/j/96039720141?pwd=TThubnVBSE1kb2hudzQ1TVZ0OEovUT09\n\n\n \nMeeting ID: 960 3972 0141\n\n\n \nPassword: Sernova\n\n\n \nA recording will be available following the meeting at www.sernova.com/investor/agm \n\n\n \nAbout Sernova's Cell Pouch System \n\n\n \nThe Cell Pouch(TM), as part of the Cell Pouch System, is a novel, proprietary, scalable, implantable macroencapsulation device solution designed for the long-term survival and function of therapeutic cells. The device upon implantation is designed to incorporate with tissue, forming highly vascularized tissue chambers for the transplantation and function of therapeutic cells, which then release proteins and hormones as required to treat disease. The Cell Pouch, along with therapeutic cells, has been shown to provide long-term safety and efficacy in small...